Literature DB >> 16936236

Inhibition of reactive nitrogen species production in COPD airways: comparison of inhaled corticosteroid and oral theophylline.

T Hirano1, T Yamagata, M Gohda, Y Yamagata, T Ichikawa, S Yanagisawa, K Ueshima, K Akamatsu, M Nakanishi, K Matsunaga, Y Minakata, M Ichinose.   

Abstract

BACKGROUND: Reactive nitrogen species (RNS) are thought to be one of the important factors in the pathogenesis of chronic obstructive pulmonary disease (COPD). A study was undertaken to examine the effects of theophylline and fluticasone propionate (FP) on RNS production in subjects with COPD.
METHODS: Sixteen COPD subjects participated in the study. Theophylline (400 mg/day orally) or FP (400 mug/day inhalation) were administered for 4 weeks in a randomised crossover manner with a washout period of 4 weeks. Induced sputum was collected at the beginning and end of each treatment period. 3-nitrotyrosine (3-NT), which is a footprint of RNS, was quantified by high performance liquid chromatography with an electrochemical detection method as well as by immunohistochemical staining.
RESULTS: Theophylline significantly reduced the level of 3-NT in the sputum supernatant as well as the number of 3-NT positive cells (both p<0.01). FP also reduced 3-NT formation, but the effect was smaller than that of theophylline. Theophylline also significantly reduced the neutrophil cell counts in the sputum (p<0.01), while FP treatment had no effect on the number of inflammatory cells in the sputum, except eosinophils.
CONCLUSIONS: Theophylline reduces nitrative stress and neutrophil infiltration in COPD airways to a larger extent than inhaled corticosteroid.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936236      PMCID: PMC2117093          DOI: 10.1136/thx.200X.058156

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  29 in total

Review 1.  Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

Review 2.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Systemic oxidative stress in asthma, COPD, and smokers.

Authors:  I Rahman; D Morrison; K Donaldson; W MacNee
Journal:  Am J Respir Crit Care Med       Date:  1996-10       Impact factor: 21.405

4.  Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide.

Authors:  T Okamoto; T Akaike; T Nagano; S Miyajima; M Suga; M Ando; K Ichimori; H Maeda
Journal:  Arch Biochem Biophys       Date:  1997-06-15       Impact factor: 4.013

5.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.

Authors:  J S Beckman; T W Beckman; J Chen; P A Marshall; B A Freeman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 6.  Reactive oxygen species and airway inflammation.

Authors:  P J Barnes
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

Review 7.  Theophylline in chronic obstructive pulmonary disease: new horizons.

Authors:  Peter J Barnes
Journal:  Proc Am Thorac Soc       Date:  2005

Review 8.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

9.  Use of induced sputum cell counts to investigate airway inflammation in asthma.

Authors:  I Pin; P G Gibson; R Kolendowicz; A Girgis-Gabardo; J A Denburg; F E Hargreave; J Dolovich
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

10.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.

Authors:  V M Keatings; P D Collins; D M Scott; P J Barnes
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

View more
  10 in total

1.  Theophylline for COPD.

Authors:  P J Barnes
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

2.  Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential.

Authors:  Neeraj Vij
Journal:  Expert Opin Drug Deliv       Date:  2011-06-28       Impact factor: 6.648

3.  The influence of free 3-nitrotyrosine and saliva on the quantitative analysis of protein-bound 3-nitrotyrosine in sputum.

Authors:  Kazuhito Ueshima; Yoshiaki Minakata; Hisatoshi Sugiura; Satoru Yanagisawa; Tomohiro Ichikawa; Keiichirou Akamatsu; Tsunahiko Hirano; Masanori Nakanishi; Kazuto Matsunaga; Toshiyuki Yamagata; Masakazu Ichinose
Journal:  Anal Chem Insights       Date:  2007-02-14

4.  Low-dose theophylline in addition to ICS therapy in COPD patients: A systematic review and meta-analysis.

Authors:  Tiankui Shuai; Chuchu Zhang; Meng Zhang; Yalei Wang; Huaiyu Xiong; Qiangru Huang; Jian Liu
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

Review 5.  Adenosine A2A receptor antagonists: from caffeine to selective non-xanthines.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao; Pierre Matricon; Matthew T Eddy; Jens Carlsson
Journal:  Br J Pharmacol       Date:  2020-06-19       Impact factor: 9.473

Review 6.  Late-onset asthma: current perspectives.

Authors:  Tsunahiko Hirano; Kazuto Matsunaga
Journal:  J Asthma Allergy       Date:  2018-02-09

Review 7.  Post-tuberculous lung disease: should we be using Theophylline?

Authors:  Sumanth Karamchand; Morne Williams; Poobalan Naidoo; Eric Decloedt; Brian Allwood
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

8.  Effect of add-on therapy of tiotropium in COPD treated with theophylline.

Authors:  Tomotaka Kawayama; Tomoaki Hoshino; Masao Ichiki; Toru Tsuda; Masaharu Kinoshita; Shohei Takata; Takeharu Koga; Tomoaki Iwanaga; Hisamichi Aizawa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 9.  Theophylline.

Authors:  Peter J Barnes
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-18

Review 10.  Oxidative Stress Markers in Sputum.

Authors:  Balazs Antus
Journal:  Oxid Med Cell Longev       Date:  2016-01-14       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.